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Background
The 6-oxopurine phosphoribosyltransferases have been
suggested to be a target for the discovery of new antima-
larial drugs. This is because protozoan parasites rely solely
on the salvage of purines from their host to make the
nucleotides needed for RNA and DNA synthesis and lack
the de novo pathway. Acyclic nucleoside phosphonates
(ANPs) that contain a 6-oxopurine base are good inhibi-
tors of the Plasmodium falciparum (Pf) and Plasmodium
vivax (Pv) 6-oxopurine phosphoribosyltransferases (PRTs)
[1]. Chemical modifications based on the crystal structure
of 2-(phosphonoethoxy) ethylguanine (PEEG) in complex
with human HGPRT have led to the design of new ANPs
[2]. These novel compounds contain a second phospho-
nate group attached to the ANP scaffold [3].
Results
{[(2-[(Guanine-9Hyl)methyl]propane-1,3-diyl)bis(oxy)]bis
(me thy-lene)} diphosphonic acid exhibited a Ki value of 30
nM for human HGPRT and 70 nM for Pf HGXPRT. The
crystal structure of this compound in complex with human
HGPRT shows that it fills or partially fills three critical
locations in the active site: the binding sites of the purine
base, the 5’-phosphate group, and pyrophosphate [3]. This
is the first HG(X) PRT inhibitor that has been able to
achieve this result. Pro-drugs have been synthesized result-
ing in IC50 values as low as 3.8 μM for Pf grown in cell
culture, which is up to 25-fold lower compared to the par-
ent compounds [3].
Conclusion
The crystal structure of {[(2-[(Guanine-9Hyl)methyl]
propane-1,3-diyl)bis(oxy)]bis(methylene)} diphosphonic
acid in complex with human HGPRT provides a tem-
plate for chemical modifications to increase both
potency and selectivity for the parasite enzymes.
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